Angelika Bauer

Dr. Angelika Bauer


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2025 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
AHAnna Lena Huber
Anna Lena Huber
ABAngelika Bauer
Angelika Bauer
JBJulius Beirer
Julius Beirer
KFKatharina Frede
Katharina Frede
KKKatharina Kirchmair
Katharina Kirchmair
YNYvonne Nowosielski
Yvonne Nowosielski

23 April 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
ABAngelika Bauer
Angelika Bauer
AMAstrid Mayr
Astrid Mayr
STStephanie Toepfer
Stephanie Toepfer
KSKathrin Spettel
Kathrin Spettel
Birgit WillingerBirgit Willinger
Birgit Willinger
CLCornelia Lass-Flörl
Cornelia Lass-Flörl
Candidozyma auris (C. auris) is an emerging healthcare-associated yeast of major epidemiological concern because of its multidrug resistance and outbreak potential. We report the recovery of a single C. auris isolate from a used face mask collected in May 2025 during a blinded dental medicine quality-control programme assessing microbial contamination in the working environment. To contextualise this finding, we analysed routine diagnostic laboratory data from 2017 to 2025. The isolate underwent whole-genome sequencing for molecular characterisation, including analysis of the ERG11 gene, and antifungal susceptibility testing by EUCAST broth microdilution. In addition, 53,802 patient-related Candida spp. isolates collected between 2017 and 2025 were reviewed retrospectively; species identification had been performed by MALDI-TOF. The environmental isolate belonged to clade III and carried the V125A/F126L substitutions in ERG11, consistent with African clade isolates and associated with intrinsically high fluconazole minimum inhibitory concentrations. No C. auris was detected in routine patient specimens during the study period, whereas Candida albicans remained the predominant species in clinical samples. These findings provide no evidence of ongoing C. auris transmission at the Medical University of Innsbruck, but highlight the need for continued vigilance and robust infection-prevention measures to limit the risk posed by isolated introductions.